ESR1 and triple-negative breast carcinoma: MDA-MB-231 is a highly aggressive, invasive, and poorly differentiated triple-negative breast cancer (TNBC) cell line as it lacks estrogen (ER), progesterone (PR), and HER2 (human epidermal growth factor receptor) expression.